Professor Gregory Lip
Consultant Cardiologist
Contact Details
Academic PA: Luine McRae – Email: luine@liverpool.ac.uk
Tel: 0151 794 9020
For clinical matters, NHS PA: ShirleyRatcliffe.
Shirley.Ratcliffe@lhch.nhs.uk
Tel: 0151 254 3212
Professor Lip, MD, is Price-Evans Chair of Cardiovascular Medicine, at the University of Liverpool, UK – and Director of the Liverpool Centre for Cardiovascular Science at the University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital (LHCH); Honorary Consultant Cardiologist at LHCH. He is also Distinguished Professor at Aalborg University, Denmark; Adjunct Professor at Yonsei University and Seoul National University, Seoul, Korea. He also holds Visiting or Honorary Professorships in various other Universities in UK, Serbia (Belgrade), China (Beijing, Nanjing, Guangzhou), Thailand (Chiangmai) and Taiwan (Taipei).
Responsibilities at LHCH
Consultant cardiologist with specialist clinical interests in atrial fibrillation, hypertension, etc. Lead for hypertension service. Director of the Liverpool Centre for Cardiovascular Science at LHCH.
Area of Practice
Outpatients, Inpatients, Research & Innovation.
Special Clinical Interests
Professor Lip has had a major interest into the epidemiology of atrial fibrillation (AF), as well as the pathophysiology of thromboembolism in this arrhythmia. Furthermore, he has been researching stroke and bleeding risk factors, and improvements in clinical risk stratification. The CHA2DS2-VASc and HAS-BLED scores - for assessing stroke and bleeding risk, respectively – were first proposed and independently validated following his research, and are now incorporated into international guidelines.
The ABC (Atrial fibrillation Better Care) pathway proposed by him is recommended in the European, Asia-Pacific and US guidelines, and implementation has been shown to reduce adverse outcomes in AF patients.
Research Interests
In 2014, Professor Lip was ranked by Expertscape as the world's leading expert in the understanding and treatment of AF [http://bit.ly/2apB1Dt], a position still maintained in 2023 (https://bit.ly/3eP3qR4).
In 2023, he was awarded the American College of Cardiology (ACC) Distinguished Scientist Award (Clinical Domain) (https://bit.ly/3DDs0Dm).
Current Membership of Professional Regional and National Bodies
Professor Lip was on the writing committee for various international guidelines, including the American College of Chest Physicians (ACCP) Antithrombotic Therapy Guidelines for Atrial Fibrillation, as well as various guidelines and/or position statements from the European Society of Cardiology (ESC), American Heart Association (AHA) or European Heart Rhythm Association (EHRA.
About you
Good food, travel
Publications
~3797 publications cited on PubMed/Medline, on atrial fibrillation, hypertension, stroke, thrombosis, antithrombotic therapy, etc. h-index 241, i10-index 1895; 527424 citations on Google Scholar, as on 2 May 2023; >£50 million research income.
Links: Google scholar profile: https://scholar.google.co.uk/citations?user=cqY4wxQAAAAJ&hl=en
Publications on PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=lip+g&sort=date&size=200
AD Scientific Index Rankings: https://www.adscientificindex.com/scientist.php?id=1590656